Lung cancer: open trials in Chile

36 open trials have a site in Chile. Registry data; only the trial team decides who can take part.

NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Biocinetic servicios medicos limitada, Santiago · Fundacion Arturo Lopez Perez, Santiago · Orlandi Oncologia, Santiago · Centro de Investigacion del Maule, Talca · Clinica CIDO, Temuco · James Lind Centro De Investigacion Del Cancer, Temuco · Onco Centro Apys, Viña del Mar
Registry updated 2026-11-06
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Bradford Hill Norte, Antofagasta · Centro de Oncologia de Precision, Las Condes · Bradfordhill, Santiago · FALP, Santiago · Oncocentro APYS - Centro de Atencion Medica Oncologica Integral, Viña del Mar
Registry updated 2026-11-05
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
K2 Oncology, Providencia · Bradfordhill, Santiago · Centro de Oncologia de Precision, Santiago · FALP, Santiago
Registry updated 2026-11-04
NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bradford Hill Norte (Site 0516), Antofagasta · Orlandi Oncologia-Oncology (Site 0504), Santiago · Bradfordhill-Clinical Area (Site 0507), Santiago · FALP-UIDO (Site 0509), Santiago · Clinica Universidad Catolica del Maule-Oncology (Site 0501), Talca
Registry updated 2026-11-03
NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Trial Treatment · Phase 2/3 · BioNTech SE
Bradford Hill Norte, Antofagasta · Clinica MEDS, Lo Barnechea · Centro De Investigacion Clinica Bradford Hill, Recoleta · Centro de Estudios Clinicos e Investigaciones Medicas (CECIM), Santiago · Orlandi Oncologia, Santiago
Registry updated 2026-11-02
NCT07195695
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Trial Treatment · Phase 3 · Boehringer Ingelheim
Centro de Estudios Clínicos SAGA, Providencia · Bradford Hill- Centro de Investigacion Clinica, Recoleta
Registry updated 2026-11-02
NCT07431827
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Clínica MEDS La Dehesa (Site 0509), Lo Barnechea · Bradford Hill (Site 0508), Santiago · Centro de Oncología de Precisión (Site 0503), Santiago · Fundación Arturo López Pérez (Site 0501), Santiago
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Local Institution - Unk028, Santiago · Local Institution - 007-699, Santiago · Local Institution - Unk073, Temuco
Registry updated 2026-10-30
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bradford Hill Norte (Site 2563), Antofagasta · Bradfordhill (Site 2552), Santiago · Orlandi Oncologia (Site 2555), Santiago · Fundación Arturo López Pérez (Site 2551), Santiago · Clínica RedSalud Vitacura (Site 2556), Santiago · ONCOCENTRO APYS (Site 2554), Viña del Mar
Registry updated 2026-10-30
NCT07513376
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bradford Hill Norte (Site 3705), Antofagasta · Clínica MEDS La Dehesa (Site 3708), Lo Barnechea · Centro de Oncología de Precisión (Site 3706), Santiago · Bradfordhill-Clinical Area (Site 3700), Santiago · FALP-UIDO (Site 3701), Santiago · ONCOCENTRO APYS-ACEREY (Site 3704), Viña del Mar
Registry updated 2026-10-30
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AbbVie
Icegclinic /Id# 231212, La Florida · Sociedad Prosalud Montes y Orlandi /ID# 231154, Providencia · Fundacion Arturo Lopez Perez /ID# 231151, Providencia · Sociedad Oncovida /ID# 231152, Providencia · Hospital Clinico Universidad De Los Andes /ID# 260974, Santiago · Clinica Universidad Catolica del Maule /ID# 231294, Talca
Registry updated 2026-10-29
NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bradford Hill Norte (Site 0420), Antofagasta · Pontificia Universidad Catolica de Chile-Hemato-Oncology (Site 0402), Santiago · Bradfordhill-Clinical Area (Site 0407), Santiago · Fundación Arturo López Pérez (Site 0409), Santiago · Centro de Investigación del Maule (Site 0419), Talca · ONCOCENTRO APYS-ACEREY (Site 0400), Viña del Mar
Registry updated 2026-10-29
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Icegclinic, La Florida · Instituto Oncologico FALP, Providencia · Clinica Santa Maria, Providencia · Bradford Hill- Centro de Investigacion Clinica, Recoleta · Clinica Alemana de Santiago S.A., Santiago
Registry updated 2026-10-28
NCT06772623
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Trial Treatment · Phase 1/2 · AbbVie
Oncored /Id# 281108, Vitacura
Registry updated 2026-10-27
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial Treatment · Phase 3 · Mirati Therapeutics Inc.
Bradfordhill, Recoleta · FALP, Santiago
Registry updated 2026-10-27
NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Orlandi Oncologia-Oncology (Site 0503), Santiago · FALP-UIDO (Site 0501), Santiago · Bradfordhill-Clinical Area (Site 0504), Santiago · Centro de Oncología de Precisión (Site 0502), Santiago · Clinica Universidad Catolica del Maule-Oncology (Site 0500), Talca
Registry updated 2026-10-26
NCT07190248
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centro de Estudios Clínicos SAGA (Site 0503), Santiago · Fundación Arturo López Pérez (Site 0500), Santiago · Bradfordhill (Site 0501), Santiago
Registry updated 2026-10-26
NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Instituto del Cancer Redsalud, Santiago · Pontificia Universidad Catolica de Chile, Santiago · Orlandi Oncologia, Santiago · Fundacion Arturo Lopez Perez (FALP), Santiago · Bradfordhill, Santiago · Oncocentro Apys, Viña del Mar
Registry updated 2026-10-23
NCT06899126
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Daiichi Sankyo
Biocenter, Concepción · Centro de Investigacion Clinica Bradford Hill, Santiago · Centro de Oncologia de Precision, Santiago · Clinica Redsalud Vitacura, Santiago · Orlandi Oncologia, Santiago · Hospital Clínico Universidad de Chile, Santiago
Registry updated 2026-10-23
NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Antofagasta · Providencia · Recoleta · Santiago
Registry updated 2026-10-23
NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Bradford Hill Norte, Antofagasta · Servicios Medicos e Investigacion Biocenter SpA, Concepción · Instituto Nacional del Cancer, Independencia · Centro de Oncologia de Precision, Las Condes · Bradfordhill, Santiago
Registry updated 2026-10-23
NCT07680764
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
Orlandi Oncologia, Santiago · Bradfordhill, Santiago · Oncocentro Apys, Viña del Mar
Registry updated 2026-10-23
NCT07227597
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Pontificia Universidad Catolica de Chile (Site 0202), Santiago · Bradfordhill (Site 0201), Santiago · Fundación Arturo López Pérez (Site 0200), Santiago
Registry updated 2026-10-20
NCT06731907
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Bradfordhill (Site 0160), Santiago · Centro de Estudios Clínicos SAGA (Site 0162), Santiago · Fundación Arturo López Pérez (Site 0161), Santiago
Registry updated 2026-10-16
NCT06312137
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
FALP-UIDO (Site 0401), Providencia · Centro de Estudios Clínicos SAGA-CECSAGA (Site 0404), Santiago · Bradfordhill-Clinical Area (Site 0400), Santiago · Clínica RedSalud Vitacura (Site 0412), Santiago · ONCOCENTRO APYS-ACEREY (Site 0410), Viña del Mar
Registry updated 2026-10-15

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error